🇺🇸 FDA
Patent

US 8835493

Oligo-benzamide compounds for use in treating cancers

granted A61KA61K31/167A61K31/235

Quick answer

US patent 8835493 (Oligo-benzamide compounds for use in treating cancers) held by The Board of Regents of the University of Texas System expires Mon Sep 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Sep 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
45
CPC classes
A61K, A61K31/167, A61K31/235, A61K38/03, A61K45/06